Nomura Research Institute, Ltd.
NRILY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,365 | $195,770 | $196,568 | $191,467 |
| % Growth | -99.3% | -0.4% | 2.7% | – |
| Cost of Goods Sold | $847 | $124,198 | $126,858 | $120,602 |
| Gross Profit | $518 | $71,572 | $69,710 | $70,865 |
| % Margin | 38% | 36.6% | 35.5% | 37% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $237 | $34,864 | $37,571 | $34,954 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$538 | -$415 | -$807 |
| Operating Expenses | $237 | $34,326 | $37,156 | $34,147 |
| Operating Income | $281 | $37,246 | $32,554 | $36,718 |
| % Margin | 20.6% | 19% | 16.6% | 19.2% |
| Other Income/Exp. Net | $0 | $731 | $20 | -$567 |
| Pre-Tax Income | $281 | $37,977 | $32,574 | $36,151 |
| Tax Expense | $93 | $11,858 | $10,394 | $9,879 |
| Net Income | $187 | $26,000 | $21,967 | $26,142 |
| % Margin | 13.7% | 13.3% | 11.2% | 13.7% |
| EPS | 0.33 | 45.43 | 38.4 | 45.73 |
| % Growth | -99.3% | 18.3% | -16% | – |
| EPS Diluted | 0.33 | 45.43 | 38.4 | 45.73 |
| Weighted Avg Shares Out | 573 | 572 | 572 | 572 |
| Weighted Avg Shares Out Dil | 573 | 572 | 572 | 572 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $733 | $20 | $0 |
| Interest Expense | $8 | $0 | $0 | $566 |
| Depreciation & Amortization | $85 | $12,207 | $12,301 | $12,115 |
| EBITDA | $373 | $49,169 | $44,713 | $48,403 |
| % Margin | 27.3% | 25.1% | 22.7% | 25.3% |